0. DOCID:24004 SCORE: 0.000250023934138709
DOCNO: 11682928
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Survival Rate
QUALIFIER: standards
QUALIFIER: standards
QUALIFIER: nursing
PUBTYPE: Journal Article
JOURNALTITLE: Clinical resource management.
COUNTRY: United States
TITLE: More educated nurses prove cost-effective for the sickest patients.
PUBDATE: 20011001
Follow-up by advanced practice nurses--as opposed to traditionally trained RNs--is associated with better outcomes among cancer patients.


1. DOCID:27728 SCORE: 0.000250018193756397
DOCNO: 9848370
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: physiology
QUALIFIER: blood supply
QUALIFIER: physiopathology
AUTHOR: H M Pinedo HM
AUTHOR: H M Verheul HM
AUTHOR: R J D'Amato RJ
AUTHOR: J Folkman J
AFFILIATION: Department of Medical Oncology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands.
PUBTYPE: Journal Article
JOURNALTITLE: Lancet.
COUNTRY: ENGLAND
TITLE: Involvement of platelets in tumour angiogenesis?
PUBDATE: 19981101
Preclinical and clinical research show that tumour growth is dependent on angiogenesis. Activation of the coagulation cascade is commonly found in patients with cancer. We propose that platelets contribute to tumour-induced angiogenesis. The basis of our hypothesis is that platelets are a rich source of stimulators and inhibitors of angiogenesis and their interaction with the endothelium. Presumably, the antithrombotic state of normal endothelium is disturbed by endothelial stimuli derived from tumour cells. This hypothesis may explain the suggested clinical benefits of anticoagulants in cancer and implies that targeting of platelet interaction with tumour vasculature will inhibit angiogenesis.


2. DOCID:24034 SCORE: 0.000250016407711069
DOCNO: 10101465
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: surgery
AUTHOR: W I Krasnodebski WI
AUTHOR: D Kopeć D
AFFILIATION: Katedry i Kliniki Chirurgii Gastroenterologicznej AM w Warszawie.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
COUNTRY: POLAND
TITLE: [Results of treatment of the cancer of the large intestine in elderly patients]
PUBDATE: 19980801
In the surgical management of colorectal cancer was disscussed and clinico-pathological features of prognostic significance were undelined.


3. DOCID:24215 SCORE: 0.000250015251097188
DOCNO: 9616560
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Critical Pathways
QUALIFIER: surgery
AUTHOR: R A Tucci RA
AUTHOR: K L Bartels KL
AFFILIATION: Lankenau Hospital, Main Health Systems, Wynnewood, PA, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Clinical journal of oncology nursing.
COUNTRY: UNITED STATES
TITLE: Ovarian cancer surgery: a clinical pathway.
PUBDATE: 19980401
Clinical pathways are useful tools in providing quality care while decreasing the cost of that care. Pathways help to facilitate managed care, identify patient and family educational needs, encourage multidisciplinary communication, and expedite patient discharge. This article discusses a clinical pathway for ovarian cancer surgery.


4. DOCID:28058 SCORE: 0.000250012882140227
DOCNO: 12565007
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
QUALIFIER: trends
QUALIFIER: therapeutic use
QUALIFIER: therapeutic use
AUTHOR: Andrew D Westwell AD
AFFILIATION: School of Pharmaceutical Sciences, University of Nottingham, University Park, Nottingham, UK NG7 2RD. Andrew.Westwell@nottingham.ac.uk
PUBTYPE: Journal Article
JOURNALTITLE: Drug discovery today.
COUNTRY: England
TITLE: A new era in cancer therapeutics?
PUBDATE: 20030101
Highlights from the 14th EORTC-NCI-AACR Symposium Molecular Targets and Cancer Therapeutics, 19-22 November 2002, in Frankfurt, Germany.


5. DOCID:28555 SCORE: 0.000250012714172963
DOCNO: 16121704
OWNER: NLM
STATUS: In-Process
AUTHOR: Tomasz Switaj T
AUTHOR: Witold Lasek W
AFFILIATION: Center of Oncology--Institute Soft Tissue/Bone Sarcoma and Melanoma Department, Roentgena 5, Warsaw 02-781, Poland. tswitaj@ib.amwaw.edu.pl
PUBTYPE: Journal Article
JOURNALTITLE: Current opinion in molecular therapeutics.
COUNTRY: England
TITLE: Technology evaluation: HYB-2055, Hybridon.
PUBDATE: 20050801
Hybridon is developing immunomodulatory oligonucleotides. including injectable HYB-2055 (IMOxine) which acts as an agonist of toll-like receptor 9, for the potential treatment of cancer. HYB-2055 is currently undergoing phase II clinical trials. The immunomodulatory oligonucleotides are also being investigated for the potential treatment of infectious diseases and immune disorders.


6. DOCID:26484 SCORE: 0.000250012404187059
DOCNO: 11063129
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: physiology
QUALIFIER: pathology
QUALIFIER: physiopathology
AUTHOR: M Molinari M
AFFILIATION: European Institute of Oncology, Milan, Italy. mmolinari@ieo.it
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Cell proliferation.
COUNTRY: ENGLAND
TITLE: Cell cycle checkpoints and their inactivation in human cancer.
PUBDATE: 20001001
Checkpoints are mechanisms that regulate progression through the cell cycle insuring that each step takes place only once and in the right sequence. Mutations of checkpoint proteins are frequent in all types of cancer as defects in cell cycle control can lead to genetic instability. This review will focus on three major areas of cell cycle transition control, with particular attention to the alterations found in human cancer. These areas include the G1/S transition, where most cancer-related defects occur, the G2/M checkpoint and its activation in response to DNA damage, and the spindle checkpoint.


7. DOCID:25738 SCORE: 0.000250011067324911
DOCNO: 11503809
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Clinical Trials, Phase II
DESCRIPTOR: Clinical Trials, Phase III
DESCRIPTOR: Health Benefit Plans, Employee
DESCRIPTOR: Insurance Coverage
PUBTYPE: Journal Article
JOURNALTITLE: Federal register.
COUNTRY: UNITED STATES
TITLE: Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); methodology for coverage of phase II and phase III clinical trials sponsored by the National Institutes of Health. Office of the Secretary; DoD. Final rule.
PUBDATE: 20010101
This final rule allows the Department of Defense to waive normal requirements so that covered beneficiaries can participate in Phase II and Phase III clinical trials sponsored or approved by the National Institutes of Health National Cancer Institute (NIH NCI). This waiver authority is expected to promote beneficiary access to promising new treatments and contribute to the development of such treatments.


8. DOCID:28300 SCORE: 0.00025001106659379
DOCNO: 15157868
AUTHOR: Anthony C Bishop AC
AFFILIATION: Amherst College, Department of Chemistry, Amherst, MA 01002 USA.
PUBTYPE: Comment
PUBTYPE: Journal Article
JOURNALTITLE: Chemistry & biology.
COUNTRY: England
TITLE: A hot spot for protein kinase inhibitor sensitivity.
PUBDATE: 20040501
ATP binding site-directed protein kinase inhibitors are potent weapons in the war on cancer. However, specific mutations at an inhibitor-sensitivity "hot spot" can render these molecules ineffective. In this issue of Chemistry & Biology, Daub and coworkers have used an array of known kinase inhibitors to systematically characterize the desensitizing effects of hot spot mutations.


9. DOCID:24743 SCORE: 0.000250010378112787
DOCNO: 9650001
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: adverse effects
QUALIFIER: chemically induced
QUALIFIER: adverse effects
AUTHOR: B V Murthy BV
AUTHOR: F Ion F
AUTHOR: J R Winstanley JR
AFFILIATION: Department of Anaesthesia, Royal Liverpool University Hospital, UK.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: European journal of anaesthesiology.
COUNTRY: ENGLAND
TITLE: Intestinal pseudo-obstruction associated with oral morphine.
PUBDATE: 19980501
Morphine is recommended as the strong opioid of choice by the World Health Organization (WHO) for cancer pain management. It is associated with delay in gastro-intestinal transit; as a result, patients may experience marked constipation. We describe a case of intestinal pseudo-obstruction associated with the use of oral morphine in a terminally ill cancer patient.


10. DOCID:24375 SCORE: 0.000250009664869644
DOCNO: 10373991
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: therapeutic use
QUALIFIER: therapy
QUALIFIER: therapy
AUTHOR: L K Swibold LK
AFFILIATION: Veterans Affairs Medical Center, Tucson, AZ, USA.
PUBTYPE: Clinical Trial
PUBTYPE: Journal Article
JOURNALTITLE: Urologic nursing : official journal of the American Urological Association Allied.
COUNTRY: UNITED STATES
TITLE: Maintenance therapy with bacillus Calmette-Guerin in patients with superficial bladder cancer.
PUBDATE: 19990301
The effectiveness of intravesical therapy with bacillus Calmette-Guerin for the treatment of superficial bladder cancer has been well established. However, there is no consensus about the optimum regimen for administering BCG. Maintenance therapy in 28 patients, results, and complications are addressed.


11. DOCID:29137 SCORE: 0.00025000941623339
DOCNO: 14998484
AUTHOR: Joachim Kienast J
AUTHOR: Wolfgang E Berdel WE
AFFILIATION: Department of Medicine, Hematology and Oncology, University of Muenster, D-48129 Muenster, Germany. kienast@uni-muenster.de
PUBTYPE: Comment
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Cancer cell.
COUNTRY: United States
TITLE: c-maf in multiple myeloma: an oncogene enhancing tumor-stroma interactions.
PUBDATE: 20040201
Gene expression profiling studies reported by Hurt et al. in this issue of Cancer Cell reveal an unexpectedly frequent overexpression of c-maf in multiple myeloma and identify molecular targets of c-maf transactivation. The results define c-maf as a prototype of a class of oncogenes that not only stimulate cell cycle progression, but also promote pathological interactions between tumor and stroma cells.


12. DOCID:28292 SCORE: 0.000250009415420897
DOCNO: 16109367
AUTHOR: Peter K Vogt PK
AUTHOR: Andreas G Bader AG
AFFILIATION: Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
PUBTYPE: Comment
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Molecular cell.
COUNTRY: United States
TITLE: Jun: stealth, stability, and transformation.
PUBDATE: 20050801
A recent paper by Wei and collaborators in Cancer Cell sheds light on the effects of one of the mutations in v-Jun and has broad implications for our understanding of control mechanisms that direct the timing of important cell cycle functions (Wei et al., 2005).


13. DOCID:24688 SCORE: 0.000250009103968787
DOCNO: 10463051
AUTHOR: R Segal R
AUTHOR: W Evans W
AUTHOR: D Johnson D
AUTHOR: J Smith J
AUTHOR: S P Colletta SP
AUTHOR: L Corsini L
AUTHOR: R Reid R
AFFILIATION: Ottawa Regional Cancer Centre, Ont. RoannevSegal@cancercare.on.ca
PUBTYPE: Journal Article
JOURNALTITLE: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
COUNTRY: CANADA
TITLE: Oncology Rehabilitation Program at the Ottawa Regional Cancer Centre: program description.
PUBDATE: 19990801
The Ottawa Regional Cancer Centre offers an Oncology Rehabilitation Program to patients with cancer. Between January 1997 and December 1998, 254 patients with cancer participated in the program. This paper describes the program and its participants. The program's strengths, limitations and future directions are also discussed.


14. DOCID:26279 SCORE: 0.000250008997063565
DOCNO: 11680028
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Mammography
DESCRIPTOR: Rural Health
DESCRIPTOR: Vaginal Smears
DESCRIPTOR: Women's Health
QUALIFIER: methods
AUTHOR: L Jaros L
AUTHOR: E D Eaker ED
AUTHOR: P L Remington PL
AFFILIATION: Security Health Plan, Marshfield, Wisconsin, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Journal of public health management and practice : JPHMP.
COUNTRY: United States
TITLE: Women's Health Alliance Intervention Study: description of a breast and cervical cancer screening program.
PUBDATE: 20010901
The Women's Health Alliance Intervention Study is a community-based intervention study designed to determine if county-based coalitions can increase breast and cervical cancer screening rates among women aged 40 and older in four rural Wisconsin counties. This article describes the intervention process and demonstrates the feasibility of rural volunteer coalitions to promote breast and cervical cancer screening in communities. An accompanying article in this issue describes the effectiveness of these interventions.